[2] 王忠诚. 神经外科学[M]. 武汉:湖北科学技术出版社, 2005:512.
[2] Wen PY, Kesari S. Malignant gliomas in adults[J]. N Engl J Med, 2008, 359(17):492 -507.
[3] Schwartzbaum JA, Fisher JL, Aldape KD, et al. Epidemiology and molecular pathology of glioma[J]. Nat Clin Praet Neurol, 2006, 2(9):494 -503.
[4] Kleihues P, Sobin LH. World Health Organization classification of tumors[J]. Cancer, 2000, 88(12):2887.
[5] Uematsu M, Ohsawa I, Aokage T, et al. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index[J]. J Neurooncol, 2005, 72(3):231 -238.
[6] Schaller MD, Borgman CA, Cobb BS, et al. pp125fak a structurally distinctive protein-tyrosine kinase associated with focal adhesions[J]. PNAS, 1992, 89(11):5192 -5196.
[7] Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer[J]. Cancer Metastasis Rev, 2009, 28(1/2):35 -49.
[8] Han DC, Guan JL. Assoeiation of focal adhesion kinase with Grb7 and its role In cell migration[J]. J Biol Chem, 1999, 274(34):24425 -24430.
[9] Luo M, Guan JL. A prominent determinant in breast cancer initiation, progression and metastasis[J]. Cancer Lett, 2010, 289(2):127 -139.
[10] Gan BY, Yoo YD, Guan JL. Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth[J]. J Biol Chem, 2006, 281 (49):37321 -37329.
[11] Teutschbein J, Schartl M, Meierjohann S. Interaction of Xiphophorus and murine Fyn with focal adhesion kinase[J]. Comp Biochem Physiol, 2009, 149(2):168 -174.
[12] Mitra SK, Mikolon D, Molina JE, et al. Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors[J]. Oncogene, 2006, 25(44):5969 -5984.
[13] Sod AK, Cofin JE, Schneider GB, et al. Biological significance of focal adhesion kinase in ovarian cancer:role in migration and invasion[J]. Am J Pathol, 2004, 165(4):1087 -1095.
[14] Jotta PY, Ganazza MA, Silva A, et al. Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia[J]. Leukemia, 2010, 24(1):239 -242.
[15] Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma:genetics, biology, and paths to treatment[J]. Genes Dev, 2007, 21(21):2683 -2710.
[16] 荆俊杰, 章翔, 吴景文, 等. 星形细胞瘤中 PTEN 和 CB 表达与侵袭性的关系[J]. 第四军医大学学报, 2000, 21(9):1109 -1111.
[17] Tohna Y, Gratas C, Biernat W, et al. PTEN(MMACI) mutationa are frequent in Primary glioblastomas ( d enovo) but not in seeondary glioblastomas[J]. J Neuropathol Exp Neurol, 1998, 57(7):684 -689.
[18] Ermoian RP, Fumiss CS, Lambom KR, et al. Dysregulation of PTEN and Protein kinase B is associated with glioma histology and Patient survival[J]. Clin Cancer Res, 2002, 8(50):1100 -1106.
[19] Dasari VR, Kaur K, Velpula KK, et al. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway[J]. PLoS One, 2010, 5(4):e10350 - e10362.
[20] Zundel W, Schindler C, Haas-Kogan D, et al. Loss of PTEN facilitates HIF-1-mediated gene expression[J]. Genes Dev, 2000, 14(4):391 -396.
[21] Gil A, Andrs-Pons A, Fernndez E, et al. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis:Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs[J]. Mol Biol Cell, 2006, 17(9):4002 -4013.
[22] Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells[J]. Cancer Res, 1998, 58(22):5002 -5008.
[23] Jiang Z, Pore N, Ceruiglia GJ, et al. Phosphatase and tensin homologue deficiency in glioblastoma eonfers resistance to radiation and tenlozo-lomide that is reversed lay the protease inhibitor nelfinavir[J]. Cancer Res, 2007, 67(9):4467 -4478.